2025-11-06 10:03:50
Latest Post
Avalon Technologies Ltd Q2FY26 consolidated net profit at Rs. 24.97 crores
CyberTech Systems and Software Ltd Q2 FY2025-26 consolidated profit at Rs. 8.65 crores
Piramal Pharma Ltd consolidated Q2FY26 loss at Rs. 99.22 crores
Syngene International Ltd Q2FY26 consolidated PAT declines to Rs. 67.1 crores
Magellanic Cloud Ltd Q2 FY2026 consolidated PAT at Rs. 27.61 crores
Stock Report
Metropolis Healthcare Ltd reports higher consolidated PAT of Rs. 52.66 crores in Q2FY26
Posted On : 2025-11-04 22:58:53( TIMEZONE : IST )
Metropolis Healthcare Limited has reported Consolidated financial results for the period ended September 30, 2025.
Financial Results (Q2 FY2026) - QoQ Comparison
The company has reported total income of Rs. 430.0824 crores during the period ended September 30, 2025 as compared to Rs. 393.5796 crores during the period ended June 30, 2025.
The company has posted net profit / (loss) of Rs. 52.6681 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs. 45.0607 crores for the period ended June 30, 2025.
The company has reported EPS of Rs. 10.13 for the period ended September 30, 2025 as compared to Rs. 8.66 for the period ended June 30, 2025.
| Financials | Q2 FY2026 | Q1 FY2026 | % Change |
| Total Income | ₹ 430.0824 crs | ₹393.5796 crs |  9.27% |
| Net Profit | ₹52.6681 crs | ₹45.0607 crs | 16.88% |
| EPS | ₹10.13 | ₹8.66 | 16.97% |
Financial Results (Q2 FY2026) - YoY Comparison
The company has reported total income of Rs. 430.0824 crores during the period ended September 30, 2025 as compared to Rs.352.9178 crores during the period ended September 30, 2024.
The company has posted net profit / (loss) of Rs.52.6681 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs.46.5188 crores for the period ended September 30, 2024.
The company has reported EPS of Rs.10.13 for the period ended September 30, 2025 as compared to Rs.9.03 for the period ended September 30, 2024.
| Financials | Q2 FY2026 | Q2 FY2025 | % Change |
| Total Income | ₹ 430.0824 crs | ₹352.9178 crs | 21.86% |
| Net Profit | ₹52.6681 crs | ₹46.5188 crs | 13.22% |
| EPS | ₹10.13 | ₹9.03 | 12.18% |
Financial Results (Half Year Ended FY2026) - YoY Comparison
The company has reported total income of Rs.823.6620 crores during the 6 Months period ended September 30, 2025 as compared to Rs.668.7307 crores during the 6 Months period ended September 30, 2024.
The company has posted net profit / (loss) of Rs.97.7289 crores for the 6 Months period ended September 30, 2025 as against net profit / (loss) of Rs.84.4661 crores for the 6 Months period ended September 30, 2024.
The company has reported EPS of Rs.18.79 for the 6 Months period ended September 30, 2025 as compared to Rs.16.40 for the 6 Months period ended September 30, 2024.
| Financials | Half Year Ended FY2026 | Half Year Ended FY2025 | % Change |
| Total Income | ₹823.6620 crs | ₹668.7307 crs | 23.17% |
| Net Profit | ₹97.7289 crs | ₹84.4661 crs | 15.70% |
| EPS | ₹18.79 | ₹16.40 | 14.57% |
Shares of Metropolis Healthcare Limited was last trading in BSE at Rs. 2031.95 as compared to the previous close of Rs. 2004.45. The total number of shares traded during the day was 1169 in over 198 trades.
The stock hit an intraday high of Rs. 2035.10 and intraday low of 2004.70. The net turnover during the day was Rs. 2368900.00.
